Cover Image

SANWA KAGAKU KENKYUSHO CO.,LTD. - Product Pipeline Review - 2012

Notice
This publication has been discontinued on September 28, 2012.

Abstract

Summary

Global Markets Direct's pharmaceuticals report, "SANWA KAGAKU KENKYUSHO CO.,LTD. - Product Pipeline Review - 2012" provides data on the SANWA KAGAKU KENKYUSHO CO.,LTD.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, SANWA KAGAKU KENKYUSHO CO.,LTD.'s corporate website, SEC filings, investor presentations and featured press releases, both from SANWA KAGAKU KENKYUSHO CO.,LTD. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Brief SANWA KAGAKU KENKYUSHO CO.,LTD. overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of SANWA KAGAKU KENKYUSHO CO.,LTD. human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of SANWA KAGAKU KENKYUSHO CO.,LTD. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the SANWA KAGAKU KENKYUSHO CO.,LTD.'s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Evaluate SANWA KAGAKU KENKYUSHO CO.,LTD.'s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of SANWA KAGAKU KENKYUSHO CO.,LTD. in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the SANWA KAGAKU KENKYUSHO CO.,LTD.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with SANWA KAGAKU KENKYUSHO CO.,LTD..
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of SANWA KAGAKU KENKYUSHO CO.,LTD. and identify potential opportunities in those areas.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • SANWA KAGAKU KENKYUSHO CO.,LTD. Snapshot
    • SANWA KAGAKU KENKYUSHO CO. LTD. 0verview
    • Key Information
    • Key Facts
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Research and Development Overview
    • Key Therapeutic Areas
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products- Monotherapy
  • SANWA KAGAKU KENKYUSHO CO.,LTD.- Pipeline Products Glance
    • SANWA KAGAKU KENKYUSHO CO.,LTD.- Late Stage Pipeline
      • Phase III Products/Combination Treatment Modalities
    • SANWA KAGAKU KENKYUSHO CO.,LTD. Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Drug Profiles
    • SK-0403
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SK-0503
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SK-0910
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SANWA KAGAKU KENKYUSHO CO.,LTD. - Pipeline Products by Route of Administration
    • SANWA KAGAKU KENKYUSHO CO.,LTD. - Pipeline Products By Mechanism of Action
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Dormant Projects
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • Fidarestat
  • SANWA KAGAKU KENKYUSHO CO. LTD. - Locations And Subsidiaries
    • Head 0ffice
  • Financial Deals Landscape
    • SANWA KAGAKU KENKYUSHO CO.,LTD., Deals Summary
  • SANWA KAGAKU KENKYUSHO CO. LTD Pharmaceuticals & Healthcare Deal Details
    • Partnerships
    • Shanghai ChemPartner Partners With SANWA KAGAKU
    • VistaGen Therapeutics Extens Research Agreement With SANWA KAGAKU
  • Licensing Agreements
    • Catalent Pharma Solutions Enters Into Licensing Agreement With Sanwa Kagaku Kenkyusho
    • SANWA KAGAKU KENKYUSHO Enters Into A Licensing Agreement With Elme Eisai
    • SANWA KAGAKU KENKYUSHO Enters Into Licensing Agreement With Kowa Company
    • VistaGen Therapeutics Enters Into Licensing Agreement With SANWA
  • Appenix
    • Methoology
    • Coverage
    • Seconary Research
    • Primary Research
    • Expert Panel Valiation
    • Contact Us
    • Disclaimer

List of Tables

  • SANWA KAGAKU KENKYUSHO CO.,LTD., Key Information
  • SANWA KAGAKU KENKYUSHO CO.,LTD., Key Facts
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Pipeline by Inication, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Pipeline by Stage of Development, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Monotherapy Proucts in Pipeline, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Phase III, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Phase II, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Pipeline By Route of Aministration, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Pipeline Proucts By Mechanism of Action, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Dormant Developmental Projects,2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Discontinue Pipeline Proucts, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD., Deals Summary
  • Shanghai ChemPartner Partners With SANWA KAGAKU
  • VistaGen Therapeutics Extens Research Agreement With SANWA KAGAKU
  • Catalent Pharma Solutions Enters Into Licensing Agreement With Sanwa Kagaku Kenkyusho
  • SANWA KAGAKU KENKYUSHO Enters Into A Licensing Agreement With Elme Eisai
  • SANWA KAGAKU KENKYUSHO Enters Into Licensing Agreement With Kowa Company
  • VistaGen Therapeutics Enters Into Licensing Agreement With SANWA

List of Figures

  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Pipeline by Inication, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Pipeline by Stage of Development, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Monotherapy Proucts in Pipeline, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Pipeline By Route of Aministration, 2012
  • SANWA KAGAKU KENKYUSHO CO.,LTD. - Pipeline Proucts By Mechanism of Action, 2012

Show More
Pricing
Not Available
Get Notified
Email me when related reports are published